BACKGROUND: A pancreatoduodenectomy (PD) is a highly advanced procedure associated with considerable post-operative complications and substantial costs. In this study the hospital costs associated with complications after PD were assessed. METHODS: A retrospective cohort study was conducted on 100 consecutive patients who underwent a pylorus-preserving (PP)PD between January 2012 and July 2013. Per patient, all complications occurring during admission or in the 30-day period after discharge were documented. All hospital costs related to the (PP)PD were defined as the costs of all medical interventions and resources during the hospitalisation period as recorded by the electronic supply tracking system. RESULTS: The median hospital costs ranged from €17 482 for a patient without complications to €55 623 for a patient with a post-operative haemorrhage. A post-operative haemorrhage was associated with a 39.6% increase in total hospital costs after adjusting for patient characteristics. Other factors significantly associated with an increase in total hospital costs were: the presence of a malignancy other than a pancreatic adenocarcinoma (29.4% cost increase), the severity grade of a complication (34.3-70.6% increase) and the presence of a post-operative infection (32.4% increase). CONCLUSIONS: This study provides an in-depth analysis of hospital costs and identifies factors that are associated with substantial cost consequences of specific complications occurring after a PD.
BACKGROUND: A pancreatoduodenectomy (PD) is a highly advanced procedure associated with considerable post-operative complications and substantial costs. In this study the hospital costs associated with complications after PD were assessed. METHODS: A retrospective cohort study was conducted on 100 consecutive patients who underwent a pylorus-preserving (PP)PD between January 2012 and July 2013. Per patient, all complications occurring during admission or in the 30-day period after discharge were documented. All hospital costs related to the (PP)PD were defined as the costs of all medical interventions and resources during the hospitalisation period as recorded by the electronic supply tracking system. RESULTS: The median hospital costs ranged from €17 482 for a patient without complications to €55 623 for a patient with a post-operative haemorrhage. A post-operative haemorrhage was associated with a 39.6% increase in total hospital costs after adjusting for patient characteristics. Other factors significantly associated with an increase in total hospital costs were: the presence of a malignancy other than a pancreatic adenocarcinoma (29.4% cost increase), the severity grade of a complication (34.3-70.6% increase) and the presence of a post-operative infection (32.4% increase). CONCLUSIONS: This study provides an in-depth analysis of hospital costs and identifies factors that are associated with substantial cost consequences of specific complications occurring after a PD.
Authors: N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma Journal: Ann Surg Date: 2005-12 Impact factor: 12.969
Authors: Jonah J Stulberg; Conor P Delaney; Duncan V Neuhauser; David C Aron; Pingfu Fu; Siran M Koroukian Journal: JAMA Date: 2010-06-23 Impact factor: 56.272
Authors: Nadia A Khan; Hude Quan; Jennifer M Bugar; Jane B Lemaire; Rollin Brant; William A Ghali Journal: J Gen Intern Med Date: 2006-02 Impact factor: 5.128
Authors: Eefje N de Vries; Hubert A Prins; Rogier M P H Crolla; Adriaan J den Outer; George van Andel; Sven H van Helden; Wolfgang S Schlack; M Agnès van Putten; Dirk J Gouma; Marcel G W Dijkgraaf; Susanne M Smorenburg; Marja A Boermeester Journal: N Engl J Med Date: 2010-11-11 Impact factor: 91.245
Authors: Brian P Chen; Marian Chen; Sean Bennett; Kristina Lemon; Kimberly A Bertens; Fady K Balaa; Guillaume Martel Journal: World J Surg Date: 2018-09 Impact factor: 3.352
Authors: Laurence Weinberg; Vidhura Ratnasekara; Anthony T Tran; Peter Kaldas; Tom Neal-Williams; Michael R D'Silva; Jackson Hua; Sean Yip; Patryck Lloyd-Donald; Luke Fletcher; Ronald Ma; Marcos V Perini; Mehrdad Nikfarjam; Dong-Kyu Lee Journal: Front Surg Date: 2022-05-30
Authors: Melinda H MacDonald; Gary Zhang; Laura Tasse; Daidong Wang; Hector De Leon; Richard Kocharian Journal: J Mater Sci Mater Med Date: 2021-09-30 Impact factor: 3.896
Authors: Hussameldin M Nour; Dimitra V Peristeri; Amiya Ahsan; Shehram Shafique; Prof Mansoor Khan; Muhammad S Sajid Journal: Ann Med Surg (Lond) Date: 2022-09-14
Authors: Ralph J A Linnemann; Bob J L Kooijman; Christian S van der Hilst; Joost Sprakel; Carlijn I Buis; Schelto Kruijff; Joost M Klaase Journal: Cancers (Basel) Date: 2021-12-14 Impact factor: 6.639